PKD2 and cholangiocarcinoma: This study first assessed the linkage of lnc-PKD2-2-3, miR-328, and GPAM with clinicopathological features in CCA patients and then evaluated their intercorrelation and effect on regulating CCA viability, mobility, and drug sensitivity.